Date Fruit Extract / Flav Cancer Research Results

DFE, Date Fruit Extract: Click to Expand ⟱
Features:
Dates (the fruit of Phoenix dactylifera) have been increasingly studied for their potential anticancer and cancer-preventive properties, mainly due to their rich phytochemical content and strong antioxidant activity.
Dates contain a broad spectrum of bioactive compounds linked to cancer prevention:
-Phenolic acids – e.g., ferulic acid, gallic acid, caffeic acid, and p-coumaric acid
-Flavonoids – e.g., quercetin, luteolin, apigenin
-Carotenoids – e.g., β-carotene, lutein
-Tannins, saponins, and sterols
-Dietary fiber and polysaccharides
These compounds have antioxidant, anti-inflammatory, and antiproliferative effects.

Date fiber and polyphenols foster beneficial gut bacteria (e.g., Bifidobacterium, Lactobacillus) that produce short-chain fatty acids (SCFAs), which protect the colon and may lower colon cancer risk.

Date Fruit Extract — a non-standardized botanical extract prepared from the edible fruit pulp of Phoenix dactylifera L., including cultivars such as Ajwa, Medjool, Hallawi, Sukkari, and others. It is classified as a complex food-derived phytochemical mixture rather than a single defined drug or active pharmaceutical ingredient. The standard abbreviation is DFE. Principal constituents vary substantially with cultivar, ripeness, processing, and extraction solvent, but commonly include phenolic acids such as gallic, ferulic, caffeic, protocatechuic, and p-coumaric acids; flavonoids such as quercetin, luteolin, apigenin, catechin, and epicatechin derivatives; carotenoids; condensed tannins; polysaccharides; and dietary fiber. Date fruit, date seed, leaf, pollen, and nanoparticle preparations are compositionally distinct and should not be treated as interchangeable with fruit-pulp extract.

Primary mechanisms (ranked):

  1. Induction of mitochondrial apoptosis in susceptible cancer cells, involving mitochondrial membrane depolarization, BAX/BCL-2 imbalance, caspase activation, and DNA fragmentation.
  2. Suppression of cancer-cell proliferation through cell-cycle arrest, with reported accumulation in G1 or G2/M phases depending on the extract, concentration, and tumor model.
  3. Redox modulation, including antioxidant protection in normal tissues but concentration-dependent ROS and mitochondrial ROS elevation in some cancer-cell models.
  4. Modulation of p53-associated stress and apoptotic signaling in responsive tumor cells.
  5. Anti-inflammatory activity through suppression of NF-κB-associated inflammatory signaling and inflammatory mediators, although direct tumor-specific evidence is limited.
  6. Secondary modulation of PI3K/AKT and related survival signaling, reported inconsistently and not established as a universal mechanism.
  7. Potential suppression of migration, clonogenic survival, angiogenic signaling, and tumor growth in selected preclinical models.
  8. Indirect colon-health effects through fermentable fiber and polyphenol interactions with the gut microbiota and production of short-chain fatty acids.

Bioavailability / PK relevance: No clinically validated pharmacokinetic profile exists for DFE as a standardized anticancer agent. Its polyphenols undergo incomplete intestinal absorption, extensive phase-II conjugation, microbial metabolism, and rapid systemic clearance. Consequently, circulating concentrations of individual parent compounds are generally much lower than concentrations used for direct cancer-cell cytotoxicity. Local gastrointestinal exposure and microbial metabolites may be more biologically relevant than systemic exposure after ordinary date consumption.

In-vitro vs systemic exposure relevance: Most antiproliferative studies use crude solvent fractions at tens to hundreds of micrograms per millilitre. These concentrations cannot be directly equated with plasma exposure after eating dates or taking an unstandardized extract. Extract-specific cytotoxic effects may reflect concentrated mixtures, solvent-selective enrichment, or interactions among multiple constituents. Common in-vitro exposures probably exceed achievable systemic concentrations from dietary intake.

Clinical evidence status: Preclinical. Evidence consists primarily of cell-culture studies, limited animal experiments, compositional studies, and small human dietary studies evaluating metabolic, inflammatory, or gastrointestinal outcomes. No randomized controlled oncology trial has established DFE as a cancer treatment, adjunctive anticancer therapy, radiosensitizer, or chemotherapy sensitizer. Date fruit and date-derived extracts are not approved by Health Canada, the FDA, or the EMA as anticancer drugs.

Safety and deployment: Whole dates are conventional foods and are generally well tolerated, but they contain substantial carbohydrate and sugar and may require portion control in people with impaired glycemic regulation. Extracts may differ markedly from the food in concentration, solvent residues, composition, and contaminant risk. Clinical interaction data with chemotherapy, anticoagulants, endocrine therapies, or targeted agents are inadequate. DFE should not be assumed to protect normal tissue selectively or improve anticancer treatment efficacy without direct combination studies.

Date Fruit Extract Mechanistic Profile

Rank Pathway / Axis Cancer Cells Normal Cells TSF Primary Effect Notes / Interpretation
1 Mitochondrial apoptosis MMP ↓; BAX ↑; BCL-2 ↓; caspase-3 ↑; apoptosis ↑ Apoptotic injury often ↓ in oxidative-damage models R, G Programmed cancer-cell death Best-supported direct anticancer mechanism, but demonstrated mainly with concentrated Ajwa or solvent-fraction extracts in vitro.
2 Cell-cycle control Proliferation ↓; G1 or G2/M arrest ↑ (model-dependent) ↔ G Cytostasis Cell-cycle phase varies by tumor line, cultivar, solvent fraction, concentration, and exposure duration.
3 ROS and mitochondrial oxidative stress ROS ↑; mitochondrial ROS ↑ (dose-dependent) ROS ↓; lipid peroxidation ↓; antioxidant capacity ↑ P, R Context-dependent redox modulation Cancer-cell pro-oxidant activity has been reported, while antioxidant protection predominates in normal-tissue injury models. Tumor selectivity is not clinically established.
4 p53 stress response p53 ↑; apoptotic signaling ↑ (model-dependent) ↔ R, G Stress-mediated growth suppression Reported in selected models and should not be generalized to p53-deficient or mutant-p53 tumors.
5 NF-κB inflammatory signaling NF-κB-associated survival and inflammation ↓ (limited evidence) Inflammatory signaling ↓ R, G Anti-inflammatory modulation More consistently supported in inflammatory or tissue-injury systems than in direct oncology experiments.
6 PI3K and AKT survival signaling PI3K/AKT ↓ (context-dependent) ↔ or AKT support ↑ in injury models R, G Survival-pathway suppression Not consistently measured across DFE studies and may partly reflect activities of individual phenolic constituents.
7 Clonogenic survival and tumor growth Colony formation ↓; tumor-cell burden ↓ in limited models ↔ G Long-term growth inhibition Evidence is substantially weaker than for established anticancer agents and remains extract-specific.
8 Migration and invasion Migration ↓; invasion-related signaling possibly ↓ ↔ G Potential antimetastatic activity Limited mechanistic data; MMP and epithelial-mesenchymal transition effects require further confirmation.
9 Angiogenic signaling VEGF-associated signaling possibly ↓ ↔ G Potential angiogenesis suppression Sparse evidence and not established as a primary effect of fruit-pulp extract.
10 NRF2 antioxidant response NRF2 modulation mixed (context-dependent) NRF2 and antioxidant enzymes ↑ R, G Secondary cytoprotective response NRF2 activation may protect normal tissues but could theoretically support antioxidant resistance in some cancers. Direct DFE tumor data are insufficient to define the net effect.
11 Gut microbiota and short-chain fatty acids Indirect colon-environment modulation Beneficial bacterial growth ↑; fermentation products ↑ G Local gastrointestinal and metabolic effect Human dietary evidence supports microbiota and bowel-environment effects more strongly than systemic anticancer activity.
12 Clinical Translation Constraint Effective exposure uncertain; extract composition heterogeneous Food-level tolerance generally favorable G Limits clinical interpretation Major constraints include cultivar and solvent variability, absent extract standardization, low systemic polyphenol exposure, high in-vitro concentrations, limited animal oncology evidence, and no controlled cancer trials.

TSF: P: 0–30 min    R: 30 min–3 hr    G: >3 hr
Flav, flavonoids: Click to Expand ⟱
Source:
Type: Ingredient

Ingredient

Polyphenols are the broad chemical family. Flavonoids are one major subgroup within that family.

| Category                | Polyphenols                                                                    | Flavonoids                                                                  |
| ----------------------- | ------------------------------------------------------------------------------ | --------------------------------------------------------------------------- |
| Scope                   | Broad umbrella term                                                            | Subclass of polyphenols                                                     |
| Main structural feature | One or more phenolic rings                                                     | Typically a 15-carbon C6–C3–C6 structure                                    |
| Includes                | Flavonoids, phenolic acids, stilbenes, lignans, tannins and related compounds  | Flavonols, flavones, flavanones, flavan-3-ols, anthocyanins and isoflavones |
| Examples                | Curcumin, resveratrol, caffeic acid, chlorogenic acid, ellagic acid, quercetin | Quercetin, kaempferol, apigenin, luteolin, EGCG, cyanidin, genistein        |
| Relationship            | All flavonoids are polyphenols                                                 | Not all polyphenols are flavonoids
|

Common Flavonoids and Their Potential Effects in Cancer and Alzheimer’s Disease

Flavonoids are a major subclass of polyphenols found in fruits, vegetables, tea, cocoa, herbs, and legumes. Major subclasses include flavonols, flavones, flavanones, flavan-3-ols, anthocyanidins, and isoflavones.

Flavonoid Subclass Common Sources Basic Potential Effect Against Cancer Basic Potential Effect in Alzheimer’s Disease (AD)
Quercetin Flavonol Onions, apples, capers, berries, kale May induce apoptosis and cell-cycle arrest and inhibit proliferation, angiogenesis, invasion, PI3K/Akt, MAPK, STAT3, and NF-κB signalling. May reduce oxidative stress, neuroinflammation, amyloid-β toxicity, tau phosphorylation, and mitochondrial dysfunction.
Kaempferol Flavonol Kale, spinach, broccoli, beans, tea May promote apoptosis and inhibit proliferation, angiogenesis, epithelial–mesenchymal transition, PI3K/Akt, and inflammatory signalling. May reduce oxidative stress, microglial activation, amyloid toxicity, neuroinflammation, and neuronal apoptosis.
Myricetin Flavonol Berries, grapes, tea, walnuts May inhibit proliferation, migration, angiogenesis, and inflammatory signalling and promote apoptosis and cell-cycle arrest. May inhibit amyloid-β aggregation, reduce oxidative injury, and support mitochondrial and neuronal function.
Fisetin Flavonol Strawberries, apples, persimmons, onions May induce apoptosis and inhibit proliferation, invasion, NF-κB, PI3K/Akt/mTOR, and epithelial–mesenchymal transition. May support synaptic function and reduce oxidative stress, neuroinflammation, senescent-cell burden, and memory impairment.
Isorhamnetin Flavonol Sea buckthorn, onions, pears, almonds May inhibit proliferation, migration, angiogenesis, and PI3K/Akt and NF-κB signalling while promoting apoptosis. May reduce oxidative stress, neuroinflammation, microglial activation, and amyloid-associated neuronal damage.
Rutin Flavonol glycoside Buckwheat, apples, citrus fruit, asparagus May inhibit oxidative damage, inflammation, proliferation, angiogenesis, and tumour-cell migration. May reduce oxidative stress, neuroinflammation, amyloid toxicity, cholinergic dysfunction, and neuronal apoptosis.
Apigenin Flavone Parsley, celery, chamomile, oregano May induce apoptosis and cell-cycle arrest and inhibit NF-κB, STAT3, PI3K/Akt, angiogenesis, invasion, and metastasis. May suppress microglial activation, inflammatory cytokines, oxidative stress, amyloid toxicity, and tau-related abnormalities.
Luteolin Flavone Celery, parsley, peppers, thyme May inhibit proliferation, angiogenesis, metastasis, NF-κB, STAT3, MAPK, and PI3K/Akt signalling and promote apoptosis. May reduce neuroinflammation, microglial activation, amyloid accumulation, tau phosphorylation, and oxidative damage.
Baicalein Flavone Chinese skullcap root May induce apoptosis, autophagy, and cell-cycle arrest and inhibit proliferation, angiogenesis, invasion, and PI3K/Akt signalling. May inhibit amyloid aggregation and reduce neuroinflammation, ferroptosis, oxidative stress, and neuronal injury.
Baicalin Flavone glycoside Chinese skullcap root May suppress proliferation, inflammation, angiogenesis, migration, and NF-κB and PI3K/Akt signalling. May reduce amyloid deposition, tau phosphorylation, neuroinflammation, oxidative stress, and neuronal apoptosis.
Chrysin Flavone Propolis, honey, passionflower May induce apoptosis and inhibit proliferation, angiogenesis, invasion, NF-κB, STAT3, and PI3K/Akt signalling. May reduce oxidative stress, neuroinflammation, amyloid toxicity, acetylcholinesterase activity, and memory impairment.
Hispidulin Flavone Artemisia, sage and other medicinal herbs May inhibit proliferation, migration, angiogenesis, and STAT3 and PI3K/Akt/mTOR signalling and promote apoptosis. May reduce neuroinflammation, oxidative stress, neuronal excitotoxicity, and cognitive dysfunction in experimental models.
Naringenin Flavanone Grapefruit, oranges, tomatoes May inhibit proliferation, migration, angiogenesis, NF-κB, and PI3K/Akt signalling and promote apoptosis and cell-cycle arrest. May reduce oxidative stress, neuroinflammation, amyloid accumulation, acetylcholinesterase activity, and mitochondrial dysfunction.
Naringin Flavanone glycoside Grapefruit and other citrus fruits May suppress proliferation, inflammation, invasion, and angiogenesis and promote apoptosis. May reduce amyloid toxicity, neuroinflammation, oxidative stress, cholinergic dysfunction, and neuronal apoptosis.
Hesperetin Flavanone Oranges, lemons and other citrus fruits May inhibit proliferation, migration, angiogenesis, and inflammatory signalling and induce apoptosis and cell-cycle arrest. May protect mitochondria and reduce oxidative stress, neuroinflammation, amyloid toxicity, and cognitive impairment.
Hesperidin Flavanone glycoside Orange and lemon peel and pulp May inhibit inflammation, proliferation, angiogenesis, and metastasis and promote apoptosis in experimental cancer models. May reduce oxidative stress, neuroinflammation, amyloid deposition, tau phosphorylation, and cholinergic dysfunction.
Eriodictyol Flavanone Citrus fruits, yerba santa, peppermint May suppress proliferation, migration, oxidative stress, and inflammatory signalling and promote apoptosis. May activate Nrf2-mediated antioxidant defence and reduce neuroinflammation, oxidative injury, and amyloid toxicity.
Epigallocatechin gallate (EGCG) Flavan-3-ol Green tea May inhibit proliferation, angiogenesis, invasion, EGFR, DNMT, NF-κB, and PI3K/Akt signalling and promote apoptosis. May inhibit or redirect amyloid-β aggregation, reduce tau phosphorylation and neuroinflammation, and support neuronal survival.
Epigallocatechin (EGC) Flavan-3-ol Green tea and white tea May reduce oxidative stress and inflammatory signalling and inhibit proliferation and tumour-cell survival. May reduce oxidative damage, neuroinflammation, amyloid toxicity, and neuronal injury.
Epicatechin gallate (ECG) Flavan-3-ol Green tea May inhibit proliferation, inflammatory signalling, angiogenesis, and tumour-cell invasion. May inhibit amyloid aggregation and reduce oxidative stress, neuroinflammation, and synaptic injury.
Epicatechin Flavan-3-ol Cocoa, dark chocolate, tea, apples May reduce inflammation and oxidative injury and inhibit proliferation, angiogenesis, and metastatic signalling. May improve cerebral blood flow and synaptic plasticity and reduce oxidative stress, neuroinflammation, and cognitive decline.
Catechin Flavan-3-ol Tea, cocoa, grapes, apples May inhibit proliferation, oxidative DNA damage, angiogenesis, inflammation, and tumour-cell migration. May inhibit amyloid aggregation and reduce oxidative stress, neuroinflammation, mitochondrial injury, and neuronal apoptosis.
Procyanidins Flavan-3-ol oligomers Grape seed, cocoa, apples, cranberries May inhibit proliferation, angiogenesis, invasion, MMP activity, and inflammatory signalling and promote apoptosis. May reduce amyloid aggregation, oxidative stress, neuroinflammation, synaptic damage, and cognitive impairment.
Cyanidin Anthocyanidin Berries, cherries, red cabbage, black rice May inhibit proliferation, inflammation, angiogenesis, invasion, and metastatic signalling and promote apoptosis. May reduce oxidative stress, neuroinflammation, amyloid toxicity, and synaptic dysfunction.
Cyanidin-3-glucoside Anthocyanin Blackberries, blueberries, cherries, black rice May suppress proliferation, inflammation, angiogenesis, and metastatic signalling and promote apoptosis. May support memory and synaptic function and reduce amyloid toxicity, neuroinflammation, and oxidative damage.
Delphinidin Anthocyanidin Blueberries, blackcurrants, purple grapes May inhibit proliferation, angiogenesis, invasion, EGFR, and inflammatory signalling and promote apoptosis. May reduce oxidative stress, microglial activation, neuroinflammation, and amyloid-associated neuronal injury.
Malvidin Anthocyanidin Blueberries, grapes, red wine May inhibit proliferation, inflammation, invasion, and oxidative damage and promote apoptosis. May reduce oxidative stress, neuroinflammation, amyloid toxicity, and cognitive dysfunction.
Pelargonidin Anthocyanidin Strawberries, raspberries, red radish May inhibit proliferation and inflammatory signalling and promote apoptosis in experimental cancer models. May reduce oxidative stress, neuroinflammation, amyloid-associated damage, and neuronal apoptosis.
Genistein Isoflavone Soybeans, tofu, tempeh May inhibit tyrosine kinases, proliferation, angiogenesis, and hormone-dependent signalling and promote apoptosis. May reduce oxidative stress and neuroinflammation and support mitochondrial and estrogen-receptor-mediated neuronal protection.
Daidzein Isoflavone Soybeans and other legumes May modulate estrogen receptors, inhibit proliferation and migration, and promote apoptosis in some hormone-responsive cancers. May provide estrogen-receptor-mediated neuroprotection and reduce oxidative stress, inflammation, and cognitive dysfunction.
Glycitein Isoflavone Soybeans and soy products May modulate estrogen-receptor signalling and inhibit oxidative stress and proliferation; evidence is less extensive than for genistein. May provide antioxidant and estrogen-receptor-mediated neuronal protection, but AD-specific evidence remains limited.
Equol Isoflavonoid metabolite Gut-microbial metabolite of daidzein May modulate estrogen receptors and inhibit proliferation, inflammation, and oxidative stress; effects can depend on cancer type. May support neuronal antioxidant defence, mitochondrial function, cerebral circulation, and estrogen-receptor-mediated neuroprotection.

Major Flavonoid Subclasses

  • Flavonols: quercetin, kaempferol, myricetin and fisetin
  • Flavones: apigenin, luteolin, baicalein and chrysin
  • Flavanones: naringenin, hesperetin and eriodictyol
  • Flavan-3-ols: catechin, epicatechin and EGCG
  • Anthocyanidins: cyanidin, delphinidin, malvidin and pelargonidin
  • Isoflavones: genistein, daidzein and glycitein

Frequently Modulated Cancer Targets and Pathways

NF-κB, STAT3, PI3K/Akt/mTOR, MAPK/ERK, Wnt/β-catenin, EGFR, p53, BCL-2, BAX, caspases, cyclins, CDKs, VEGF, HIF-1α, MMP-2, MMP-9, Nrf2/HO-1, AMPK, autophagy, angiogenesis, epithelial–mesenchymal transition, invasion, and metastasis.

Frequently Modulated Alzheimer’s Disease Targets and Pathways

Amyloid-β aggregation, APP processing, BACE1, tau phosphorylation, GSK-3β, acetylcholinesterase, microglial activation, NF-κB, NLRP3, Nrf2/HO-1, SIRT1, AMPK, CREB/BDNF, mitochondrial function, autophagy, synaptic plasticity, oxidative stress, and inflammatory cytokines.

Evidence note: Most reported anticancer and Alzheimer’s-related effects are derived from cell-culture and animal studies. Human efficacy has not been established for most individual flavonoids. Absorption, metabolism, gut-microbial conversion, dose, formulation, and blood–brain-barrier penetration can substantially affect biological activity. Flavonoids should not be considered substitutes for established cancer or Alzheimer’s disease treatments.



Scientific Papers found: Click to Expand⟱
6667- DFE,    Immunostimulant effect of dates (Phoenix dactylifera) on humoral and cellular immunity cells and their functions
- in-vivo, Nor, NA
*Imm↑, *Inflam↓, *Flav↑,

Showing Research Papers: 1 to 1 of 1

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 1

Pathway results for Effect on Cancer / Diseased Cells:


Total Targets: 0

Pathway results for Effect on Normal Cells:


Immune & Inflammatory Signaling(tgid=16) ⓘ

Imm↑, 1,   Inflam↓, 1,  

Ingredients & Constituents(tgid=25) ⓘ

Flav↑, 1,  
Total Targets: 3

Scientific Paper Hit Count for: Flav, flavonoids
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells

Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:%  Cells:%  prod#:371  Target#:1521  State#:%  Dir#:2
  wNotes=0  sortOrder:rid,rpid

 

Home Page